AmeriFlex Group’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

AmeriFlex Group’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.92K	Hold	15	–	–	﹤0.01%	958
2025 Q4	$1.83K	Sell	15 -15	-50%	-$1.72K	﹤0.01%	1003
2025 Q3	$3.01K	Sell	30 -6	-17%	-$540	﹤0.01%	951
2025 Q2	$3.02K	Hold	36	–	–	﹤0.01%	906
2025 Q1	$2.92K	Buy	36 +15	+71%	+$1.34K	﹤0.01%	1086
2024 Q4	$1.95K	Buy	+21	New	+$2.04K	﹤0.01%	1047

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

AmeriFlex Group's XBI Position: Q1 2026 in Review

AmeriFlex Group held its State Street SPDR S&P Biotech ETF (XBI) position steady in Q1 2026 at 15 shares worth $1.92K. The position accounts for ﹤0.01% of the portfolio, ranked #958.

AmeriFlex Group first reported a position in XBI in Q4 2024 and has held it in 6 quarters since. The position peaked at $3.02K in Q2 2025. 813 funds tracked by Wall St. Rank hold XBI as of Q1 2026.

AmeriFlex Group held 15 shares of State Street SPDR S&P Biotech ETF worth $1.92K as of Q1 2026.
AmeriFlex Group left its State Street SPDR S&P Biotech ETF share count unchanged in Q1 2026.
State Street SPDR S&P Biotech ETF made up ﹤0.01% of AmeriFlex Group's portfolio in Q1 2026, its #958 holding.
AmeriFlex Group first reported a position in State Street SPDR S&P Biotech ETF in Q4 2024 and has held it in 6 quarters since.
AmeriFlex Group's State Street SPDR S&P Biotech ETF position peaked at $3.02K in Q2 2025.
813 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2026.

Based on AmeriFlex Group's 13F filing for Q1 2026, filed 15 May 2026.